Cargando…
The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target
[Image: see text] As the central figure of the cellular protein degradation machinery, the proteasome is critical for cell survival. Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target. However, recent advances in the prot...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571462/ https://www.ncbi.nlm.nih.gov/pubmed/28852696 http://dx.doi.org/10.1021/acscentsci.7b00252 |
_version_ | 1783259343133605888 |
---|---|
author | Cromm, Philipp M. Crews, Craig M. |
author_facet | Cromm, Philipp M. Crews, Craig M. |
author_sort | Cromm, Philipp M. |
collection | PubMed |
description | [Image: see text] As the central figure of the cellular protein degradation machinery, the proteasome is critical for cell survival. Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target. However, recent advances in the protein homeostasis field suggest that additional chapters can be added to this successful story. For example, selective immunoproteasome inhibition promises high clinical efficacy for autoimmune disorders and inflammation, and proteasome inhibitors might serve as novel therapeutics for malaria or other microorganisms. Furthermore, utilizing the destructive force of the proteasome for selective degradation of essential drivers of human disorders has opened up a new and exciting area of drug discovery. Thus, the field of proteasome drug discovery still holds exciting questions to be answered and does not simply end with inhibiting the constitutive proteasome. |
format | Online Article Text |
id | pubmed-5571462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-55714622017-08-29 The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target Cromm, Philipp M. Crews, Craig M. ACS Cent Sci [Image: see text] As the central figure of the cellular protein degradation machinery, the proteasome is critical for cell survival. Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target. However, recent advances in the protein homeostasis field suggest that additional chapters can be added to this successful story. For example, selective immunoproteasome inhibition promises high clinical efficacy for autoimmune disorders and inflammation, and proteasome inhibitors might serve as novel therapeutics for malaria or other microorganisms. Furthermore, utilizing the destructive force of the proteasome for selective degradation of essential drivers of human disorders has opened up a new and exciting area of drug discovery. Thus, the field of proteasome drug discovery still holds exciting questions to be answered and does not simply end with inhibiting the constitutive proteasome. American Chemical Society 2017-08-07 2017-08-23 /pmc/articles/PMC5571462/ /pubmed/28852696 http://dx.doi.org/10.1021/acscentsci.7b00252 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Cromm, Philipp M. Crews, Craig M. The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target |
title | The Proteasome in Modern Drug Discovery: Second Life
of a Highly Valuable Drug Target |
title_full | The Proteasome in Modern Drug Discovery: Second Life
of a Highly Valuable Drug Target |
title_fullStr | The Proteasome in Modern Drug Discovery: Second Life
of a Highly Valuable Drug Target |
title_full_unstemmed | The Proteasome in Modern Drug Discovery: Second Life
of a Highly Valuable Drug Target |
title_short | The Proteasome in Modern Drug Discovery: Second Life
of a Highly Valuable Drug Target |
title_sort | proteasome in modern drug discovery: second life
of a highly valuable drug target |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571462/ https://www.ncbi.nlm.nih.gov/pubmed/28852696 http://dx.doi.org/10.1021/acscentsci.7b00252 |
work_keys_str_mv | AT crommphilippm theproteasomeinmoderndrugdiscoverysecondlifeofahighlyvaluabledrugtarget AT crewscraigm theproteasomeinmoderndrugdiscoverysecondlifeofahighlyvaluabledrugtarget AT crommphilippm proteasomeinmoderndrugdiscoverysecondlifeofahighlyvaluabledrugtarget AT crewscraigm proteasomeinmoderndrugdiscoverysecondlifeofahighlyvaluabledrugtarget |